Home/Filings/4/0001127602-24-021925
4//SEC Filing

Rathbun Joel R. 4

Accession 0001127602-24-021925

CIK 0001122976other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 1:13 PM ET

Size

16.5 KB

Accession

0001127602-24-021925

Insider Transaction Report

Form 4
Period: 2024-08-07
Rathbun Joel R.
SVP, Mergers & Acquisitions
Transactions
  • Sale

    Common Stock

    2024-08-07$43.36/sh11,698$507,2180 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2024-08-072,5000 total
    Exercise: $38.27Exp: 2025-02-04Common Stock (2,500 underlying)
  • Exercise/Conversion

    Stock Appreciation Rights

    2024-08-0710,4000 total
    Exercise: $24.98Exp: 2026-02-10Common Stock (10,400 underlying)
  • Exercise/Conversion

    Common Stock

    2024-08-07$38.27/sh+2,500$95,67510,840 total
  • Disposition to Issuer

    Common Stock

    2024-08-07$43.58/sh2,285$99,5808,555 total
  • Exercise/Conversion

    Common Stock

    2024-08-07$24.98/sh+10,400$259,79218,955 total
  • Disposition to Issuer

    Common Stock

    2024-08-07$43.66/sh7,257$316,84111,698 total
Holdings
  • Common Stock

    (indirect: Supplemental Plan)
    28,416.08
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.21 to $43.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
  • [F2]The information in this report is based on a plan statement as of August 7, 2024.
  • [F3]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $38.27 per share and no more than one-third of the grant can vest per year during the first three years.
  • [F4]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $24.98 per share and no more than one-third of the grant can vest per year during the first three years.

Issuer

AVIENT CORP

CIK 0001122976

Entity typeother

Related Parties

1
  • filerCIK 0001661555

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 1:13 PM ET
Size
16.5 KB